Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. - Wikidata - wikimedia - TriplyDB

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

http://www.wikidata.org/entity/Q42709676

about

Intestinal microbiota and chronic constipation Aquaporins in Health and Disease: An Overview Focusing on the Gut of Different Species Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases Pathogenic role of the gut microbiota in gastrointestinal diseases Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health Steering Endogenous Butyrate Production in the Intestinal Tract of Broilers as a Tool to Improve Gut Health Factors Determining Colorectal Cancer: The Role of the Intestinal Microbiota Interactions Between the Gastrointestinal Microbiome and Clostridium difficile MicroRNA, nutrition, and cancer prevention Fecal biomarkers of intestinal health and disease in children Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review.Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood Improving healthspan via changes in gut microbiota and fermentation Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps Chemoprotective epigenetic mechanisms in a colorectal cancer model: Modulation by n-3 PUFA in combination with fermentable fiber The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disorders Gut microbiota and tacrolimus dosing in kidney transplantation Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases Effects of Sodium Butyrate Treatment on Histone Modifications and the Expression of Genes Related to Epigenetic Regulatory Mechanisms and Immune Response in European Sea Bass (Dicentrarchus Labrax) Fed a Plant-Based Diet Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders.Maternal obese-type gut microbiota differentially impact cognition, anxiety and compulsive behavior in male and female offspring in mice Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.Influence of fasting during moult on the faecal microbiota of penguins.Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions Butyrate enhances disease resistance of chickens by inducing antimicrobial host defense peptide gene expression.Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial.Tributyrin supplementation protects mice from acute ethanol-induced gut injury.The central role of the gut microbiota in chronic inflammatory diseases.Alternative splicing regulated by butyrate in bovine epithelial cells.Upregulation of GPR109A in Parkinson's disease Modulation of antimicrobial host defense peptide gene expression by free fatty acids.The influence of early life nutrition on epigenetic regulatory mechanisms of the immune system.

P2860

Q26740193-D886A78C-D3AE-4897-877C-A1144D9C8240 Q26740555-EFBB0288-F6E5-4594-AE82-302A676D77E8 Q26744514-372817DF-24C2-4662-B7CB-982D7B07E7DA Q26746677-5C6C89E2-ACB7-4348-959D-62DB697C21C6 Q26749878-8A1F0D07-D4E5-4233-92C5-43FC9D1735C6 Q26752511-66F59CAA-4C3D-456C-8DB7-FC1231173AA7 Q26765857-60A1E11B-3765-459F-99DA-489FD0FB8854 Q26770503-7693A1ED-4097-451A-B57C-2614A4BA1ECC Q26777138-FA44AED8-2EA5-4364-942E-725B1D5E3686 Q26778722-345EEF45-CB08-4087-9EB1-3692CCC5033B Q27010206-955CCF21-8B4E-4E2E-B1C2-CEC715030ED6 Q27021773-B043CE55-7013-41C7-B5AC-53B4634A6EE2 Q27692081-3D19CAC1-F974-4374-BD43-80676309644A Q28071822-1AEB87BC-8E8D-4DF4-9DC7-55866D565BE7 Q28075770-D0694321-6536-4279-9DF3-DAC7D281806C Q28084501-84291B0B-7D25-4C40-8051-A5D36E40FBAE Q28390761-FA21CCCD-521A-416B-BB87-9306CF3E04D0 Q28392829-92DC1A0E-91BB-43B4-81B4-1E5BBF3F51C6 Q28538671-3E07E4DA-60AE-4BBF-B4B1-77CD3BABD92F Q28542649-B1BF1CDA-4C6A-4AE9-95A5-F0D80FC92631 Q28545131-B1B52837-A247-4CA2-8D3C-EA6DCD70ABB6 Q28552586-9D919D6E-16E1-4469-A79B-E68F5BB24862 Q28553330-A2A76C1F-C050-4606-B3D1-15ECC86909C3 Q30404383-07665E89-14D9-438B-BE20-AA69250DCECC Q33602483-0078D3F8-D9F2-4116-834A-DD611EC91C76 Q33614335-96EA5D81-D156-4B1C-A260-FA7299F3F889 Q33616599-BB5C6DB0-8E6D-43FC-A80B-9D3405A3EF68 Q33728333-9F6E3F7E-3041-443A-B42C-2947F1E87153 Q33825468-03F17285-8691-4094-9779-DA1D2D836AAF Q33904838-602AED59-AA4B-4F0E-9138-6FEC32591BE3 Q33958897-6E387DD6-2BEA-4D38-BFA8-D6CEE272BD82 Q34071870-41612278-DE47-4B3E-AD06-1EF36B1E8D29 Q34120699-360911E5-09E0-4F5C-8489-DECA3EA37A64 Q34265202-74274FCE-604D-44CB-A017-3BA5BE65BAB3 Q34290107-145B606F-64A6-481A-BDC9-655DF3DDB98E Q34305760-377D7E89-798E-4EC8-96B8-E1D38A74F868 Q34312260-48A90B0F-1075-47AC-875F-E49AC119E491 Q34361793-C95FB19B-4B9B-4939-9F86-56E5319BE4E8 Q34482520-FB389DD9-39BF-4C2C-889D-ED52BAC916F7 Q34577954-4EB13E40-456F-487A-B1FC-1BA42AD7BF58

P2860

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

http://www.wikidata.org/entity/Q42709676

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

@en

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

@nl

type

label

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

@en

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

@nl

prefLabel

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

@en

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

@nl

P1433

Q42709676-FF292CD0-1016-49BA-B6C9-8E11AC17DAA0

P1476

Q42709676-5E3FA16D-F8D9-4474-8D75-5CABEB082293

P2093

Q42709676-08585E4D-0728-41F3-919A-D677493D3EBE

Q42709676-69EE89BF-FF53-4FF2-BC52-2DD970ED72A5

Q42709676-7AA4137B-61F4-469F-8432-507A6A66BB11

Q42709676-D46595A8-EB6C-4938-9054-BFC2DE4BB46E

P2860

Q42709676-04805936-ED7C-40EA-A623-C0C02A86237B

Q42709676-05F38415-723B-47E8-B711-F6028F4CDC27

Q42709676-063183CA-677D-413A-9298-DA0F5644D19B

Q42709676-0665A79A-CEED-4E20-B5ED-76D8EAB8DC0C

Q42709676-093AB245-6FF4-4B57-A157-5E9A9B685D0F

Q42709676-1067B4BA-DA2D-4FFA-B234-D5F11C82C45B

Q42709676-113E1E04-98F4-4BCF-9CDA-3C8300ACC095

Q42709676-15C2320C-59B7-4A2C-98CA-C79F82D31E2E

Q42709676-160D4275-ACF9-471B-B209-5A6D72521213

Q42709676-1C19FDC2-1A94-4CE4-B374-71925444AEAF

P304

Q42709676-563FCC96-98A9-4EAA-954B-0BBC95FE5BD7

P31

Q42709676-2F8D417E-E7F8-4D07-9E64-B2F58F6EF924

Q42709676-b63ea29a-6ca1-4cbe-a170-fc5fff5b3cb2

P356

Q42709676-D259BFF7-0866-419F-9040-71CD4C8AEC09

Q42709676-EFBEE752-AB89-41DC-9A0B-DB25D2C7A2E5

P407

Q42709676-EB1C8B75-23A8-49C3-A480-A04391A07628

P433

Q42709676-B19C1F90-8771-4EE1-93CC-7B0A13D28814

P478

Q42709676-3D4F78C5-E20F-4712-93ED-65CF5BD59EA0

P50

Q42709676-42AE1F9B-9B39-4F48-BA10-511996E2D215

Q42709676-8DAFC620-CF89-447A-9BAE-74D043B4DE74

P577

Q42709676-8CFAFCF3-93FF-463C-8F9C-53E0F9C92D12

P698

Q42709676-7635702A-34CF-45A6-93A6-DAA6F90F2774

P932

Q42709676-493A2617-9007-4481-AF5A-9C72134E2FE2

P356

WJG.V17.I12.+1519

WJG.V17.I12.1519

P1433

World Journal of Gastroenterology

P1476

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases

@en

P2093

Ludovica Leone

http://www.w3.org/2001/XMLSchema#string

Margherita Di Costanzo

http://www.w3.org/2001/XMLSchema#string

Monica Pedata

http://www.w3.org/2001/XMLSchema#string

Roberto Berni Canani

http://www.w3.org/2001/XMLSchema#string

P2860

Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

Molecular identification of nicotinic acid receptor

Molecular identification of high and low affinity receptors for nicotinic acid

Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study

Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study

Identification of seven novel mutations including the first two genomic rearrangements in SLC26A3 mutated in congenital chloride diarrhea

Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

Function and activation of NF-kappa B in the immune system

P304

1519-1528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V17.I12. 1519

http://www.w3.org/2001/XMLSchema#string

10.3748/WJG.V17.I12.1519

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Calignano

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21472114

http://www.w3.org/2001/XMLSchema#string

P932

3070119

http://www.w3.org/2001/XMLSchema#string